Provided by Tiger Trade Technology Pte. Ltd.

Oppenheimer

115.73
-0.2600-0.22%
Post-market: 115.730.00000.00%17:33 EDT
Volume:138.09K
Turnover:16.04M
Market Cap:1.24B
PE:12.84
High:117.36
Open:115.71
Low:114.32
Close:115.99
52wk High:123.24
52wk Low:63.81
Shares:10.71M
Float Shares:6.07M
Volume Ratio:1.02
T/O Rate:2.27%
Dividend:0.76
Dividend Rate:0.66%
EPS(TTM):9.01
EPS(LYR):13.04
ROE:10.82%
ROA:2.59%
PB:1.26
PE(LYR):8.88

Loading ...

Oppenheimer Raises Qnity Electronics Price Target to $180 From $175

MT Newswires Live
·
Aug 05

Palo Alto Networks on Track to Hit Fiscal Q4 Recurring Revenue Outlook, Oppenheimer Says

MT Newswires Live
·
Aug 05

Oppenheimer Sticks to Its Buy Rating for Custom Truck One Source (CTOS)

TIPRANKS
·
Aug 04

Oppenheimer Adjusts Ultra Clean Holdings PT to $150 From $115, Maintains Outperform Rating

MT Newswires Live
·
Aug 04

Oppenheimer Adjusts Roblox Price Target to $50 From $82, Maintains Outperform Rating

MT Newswires Live
·
Aug 04

Oppenheimer Initiates ADI Global Distribution at Outperform

MT Newswires Live
·
Aug 04

Palo Alto Networks price target raised to $400 from $350 at Oppenheimer

TIPRANKS
·
Aug 04

Backblaze price target raised to $25 from $15 at Oppenheimer

TIPRANKS
·
Aug 04

Ichor Holdings price target raised to $80 from $60 at Oppenheimer

TIPRANKS
·
Aug 04

Roblox price target lowered to $50 from $82 at Oppenheimer

TIPRANKS
·
Aug 04

Ultra Clean price target raised to $150 from $115 at Oppenheimer

TIPRANKS
·
Aug 04

Oppenheimer Downgrades Integer to Market Perform From Outperform

MT Newswires Live
·
Aug 04

Inspire Medical upgraded to Outperform from Perform at Oppenheimer

TIPRANKS
·
Aug 04

Integer downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
Aug 04

A. O. Smith Faces Near-Term Earnings Risk; Easy Comparisons, Valuation Remain Supportive, Oppenheimer Says

MT Newswires Live
·
Aug 04

Quince Therapeutics management to meet with Oppenheimer

TIPRANKS
·
Aug 04

Viking Therapeutics' VK2735 Drives Substantial Optionality, Oppenheimer Says

MT Newswires Live
·
Aug 04

E.l.f. Beauty Set for Q1 Beat on Rhode Brand, Oppenheimer Says

MT Newswires Live
·
Aug 04

Ovid Therapeutics is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 03

Ligand Pharmaceuticals Price Target Raised to $326.00/Share from $285.00 by Oppenheimer

Dow Jones
·
Aug 03